How The American Privacy Rights Act Impacts Video Surveillance
Congress is considering a bill that, if passed, would be the country’s first national regulatory framework for personal data privacy that could severely impact video surveillance, using video analytics, and in particular, facial recognition.
This report examines how the proposed law, the American Privacy Rights Act (APRA) would affect data collection vendors, service providers and users of personal data collection systems.
Executive *******
** ********, **** ***** ******** ****** the *** ** ***** ************ *********, especially ***** **** *** ******** ************** attributes **** ** ****** *********** *** possibly "********** ******" ******* ****, ** written, ******** ********* ******* **** ** practically ********** ** ********** *** ****** video ************ ************. ******* ********, **** would ***** ********-***** **** ************ ****** the *******.
*** ******** **** ******* **** *** Illinois *** ** **** ****, ************ in **** ** ******* ******** ***** businesses *** ******* ******* ********* (**** as ***** *********), ******* *** **** on ****** ********** (**** ** ******** or ******** *** ***** ********* **** technologies). ********** ******** *** **** ********.
**** *****, ** ******, ******* ****** of ******* *********** ****** ****** *** municipalities **** **** ***** - **** almost-national *** ** **** ** ********** and ******** ***** *** ****** **** this ******** ****.
**** ***-**** ******** ************* ********** *** ******** ***** **** even ********’ ****** ********* *********** ******* Act (****) *** **** ** **************.
********
******* *********, **** ** ***** ** video ************ *************, ***** ** * covered ****** ** ******* **** ***** be ****** ** *** ******* ******** is *** ****** ********* ***** *** information:
** ****** ** * ******* ****** and *** * ******* ******** **** respect ** * ******** **********, **********, retaining, ** ************ ** ****, ** the ******, ******* ** **** ******, determines *** ******** *** ***** ** the ******** **********, **********, *********, ** transferring ** ****
********, **** ***** ****** ***** **********--***** with ******* ****** ***** ******** ** at ***** $** *******--**** ******* **** from ** **** **** ***,*** *********** and ** *** **** ******* ******** data.
********** ******** *** ******** ******* ********* (whether ***** ** * ********** ****** or ******* ************) *** **** ******.
Violation ***** ***** ** *******
********** ********* ** ********** ** ***** BIPA ***** ***** ****** **** ****** be ***** * ****** ** **** a *********, ***** *** **** ******* into ****.
*** **** ******* ***** ******* ** individual ******** ******* ** ** **** than $*,*** ** **** * ************ vendor ******** ******* ****** ** ** alleged ********* ** **** ****** ***** to *****.
******.—******* ** ********* (*), ** ****** under **** ******* *** ****** ******* may ** ******* ** * ****** only **, ****** ********** **** ****** against ** ******, *** ****** ******** the ****** ** **** ******* ****** identifying *** ******** ********** ** **** title *** ****** ******* **** **** or *** ***** ********.
****** ** ****.—** *** ***** * **** ** possible ** ****** ** **** *** entity ***** *** ******* ********* *** provides *** ****** ** ******* ******* statement **** *** ********* *** **** cured *** **** ** ******* **** violations ***** *****, ** ****** *** injunctive ****** *** *** ** ********* concerning *** ******* *********.
********** ***** ** ****** ** ********** if ** “***** *** ******* ********* and ******** *** ****** ** ******* written ********* **** *** ********* *** been ***** *** **** ** ******* such ********* ***** *****.”
**** ***** **** ***** ***** ****** awards **** * ********* **** ******** financial **** ********* **** ** ******* APRA *********. ************, ** ********** ***** be ******** ** ******** ** ***** $10,000 ** ******, ** ****** *** bill ********* ** "*********** ********* ****." This ********* ***** **** **** *** number ** ******** ******* ** ******** individuals ** ** ** **********.
*********** ******* ****.—*** **** ‘‘*********** ******* ****’’ *****—
(*) *** ******* ********* **** ** not **** **** $**,*** **
(*) *** ******* ******** ** ****** harm ** ** ********** **** ********—
(*) ********* ** * ********, ************, or ********* **** **** ****** **** provider, ********, ********* ****** ******, ******, hospice, ** *********** ** ********** ******** for *******, ****** ******, ** ********* care; **
(**) ******** ******, ****** ********* ********* into *** ******* ************ ** * reasonable ********** ***** *** *************, ** discrimination ***** ** ****, *****, ********, national ******, ***, ** **********.
********’ **** *** * *** ***** states’ *********** **** *** ******** ***** of ******. * ********-*** ******* ***** be **** * *** ***** ** still * ****** *** ** *** thief ****** ** ** * ****** or **** ** *** ******* ** returned.
****** *** ***, ********* ********* ***********, especially **** **** *** *******, ** impossible. **** *** ***** ** ******* again, ********** ** ********** ***********.
Threefold ******* *********
***** **** ***** ** ***** ******* from ********* **********, ******* ******** ***** have ** ****** ********* ***********. **** would ***** ***********, *** ******* **********, and ***** *********** ** **** ******* after * *********. (**** *** ****-******** BIPA ***** ********* **** *** ******—********** lawsuits.)
***** ****, ********** ***** ** **** by ** **********–****** * ******* ***** of ******—* ******** ** ********* **** would *** ******* ** *** ***** among ******.
****** ******** ** ***** **** *** right ** *** ** ***** *****, but **** ************ **** *** **** rejected ** (**** ** ******** ** one *********). ********** **** *** ******** against ** ******* *** ***** ** sue *** **** ** ***** *******. And ******* ***** ******* ** *** last **** ***** **** ******** ** some ** **** ************ ***** ******* in *** ******’* *******.
*******, ********* *** **** **** ** worry ***** ** **** ****** **** APRA. ****** ** *******, ********* *** need ** **** *******, ***** **** smaller *** ***** ***** *******. **** could **** ******* ******** ************ *** defendants *** **********.
*** ****** ****** *** ****** ********* would ** **** *** ** **** debate. **** ***** *** *** ******* Trade ********** (***) ** *** ******* process *** **** * *** ****** for ******** **** ******* *******.
*** ***** ** *** ******* ****: state ********* ******* (***). ********* ***** petition ***** ** ** *** * violator, ** ** ** ***** ************ sue ** ****** ** *** *****. However, ** ** **** ****** *** FTC ** ***** ****** ** *** a *******.
************* ***** **** *** **** **** the ** ** **** ****. *** bill **** *** ***** *** *** rationale *** ***** **.
**** ** *** **** ***** **** a *****, ** ********* *** ********* thin, **** ******* *******. ** ******* officials, *** **** ** **** ***** that *** ****** *** ******* **********, preferably ***** **** ******** ********* ********* for *** ******. ******* ** **** option’s ************, ** ***** ** *** best ** *** ***** ******* ** likely ***** ******** *** ****** ********.
** **** ***** ** ******** *** any *********** ** *** ***** ******* to ** **** ******* *** **** defendant. *******, ********** ***** *** ** allowed ** ******* *** ******* ************.
More ********** *** **** ********
******** **** **** *********** *** ***** biometric **** **** ** ******* ** part ** *** ******* *******. ***** the ******* ** *** ********, *** policy **** ******* **** *** ********** preventative *** ********** ******* *** *********** risks *** *********.
**** ******* ****** ** ******* ******** shall *********, *********, *** ******** ********** data ******** ********* ** *******—
(*) *** ***************, *********, *** ************ of ******* ****; ***
(*) ******* **** ******* ************ ******.
*** **** ****** **** ******** **** security ********* **** **** ******* *** “size *** ********** ** *** ******* entity ** ******* ********.” *** ***** language **** ***** **** ************ ***** change ********* ** *** ****** *** scope ** ** ******'* ********* **********, as **** ** *** ******, ***********, and ****** ** *** ********* ****.
********** **** ********* ****** ***** *************** and ********** ********** ***** *** ***** relevant *******. *** ******** ******* ** a ******** ******* ***** **** ** be ******** **.
**** ***** *** *** *********** ** a ******* ******* *** * **** security ******* *** *** ******* ********. The **** ** **** *** ***** data ******* *******, *** ***** ********* would **** ***** ************* *** ********* requirements ** ****. ** **** *****, the *** ** ** **** ********* to ****** ******** **** ********* **** coherently.
Data ************ *******
**** **** ********* **** ************, ***** is **** ********* ********** ** ***********. The ****’* ******* ****** **** “(*)** measure ***** *** ********* *** **** minimization **** ***** ***** ********* ** collect *** *** **** **** *** necessary *** ******* ********." ***** ***********, including ****, ***** **** *** ******* minimization.
**** ************, **** ********** **** ** “necessary, *************, *** *******.” ********** ***** have ** ** **** ** **** they **** * *** ** ****:
** ******* ** ********—
* ******** ******* ** ******** ********* by *** ********** ** **** *** data ********, ********* *** ********** ******* administrative, ***********, ** *******-********* ********, **** as ******* ********, ********, *******, ** accounting; **
* ************* **** ** *** ** advertisement ** *** ******* ****** ** the ********** ********** *********** ****** *** context ** *** ************ **
*** * ******* ********* *********.
*******
********’ ***** ******* ** ************* ******* privacy *********** *** *********** **** ******* *** ********** ***(*****). ** ****** ** ****, ****** never ******* *** ***** ***** **** California ******** ** *********.
**** ****** ** **** ******, *** companies ***** **** * *********** *********** that ** ** ****. ** *** 2024, ******** ********* ****** * ************* portion ** ****--******* *** ******* ** sue *** ***** ********* ** *** law. ** *** **** **** *****, BIPA *** **** **** ****** ** times ** **** ********** *********** *** misusing *********’ ********* ****.
** *** ****, *** ******** **** is ** * ************* *********, *** its ********* ** ******* *** *******. We **** ****** ** *** **** progresses ** *****.
** **** ** *********** ** *** where **** *********** ****, ** ******* it **** **** ******** **** ***** enacted. *** ***** **** **** ***** were *****-**** *** ********** ************ *** legitimate ******** ******* *********, *** ******* entities *** *** **** *** **********.